ARTIVION INC (AORT) Stock Fundamental Analysis
USA - NYSE:AORT - US2289031005 - Common Stock
45.76 USD
+0.07 (+0.15%)
45.76 USD
0 (0%)
Overall AORT gets a fundamental rating of 4 out of 10. We evaluated AORT against 189 industry peers in the Health Care Equipment & Supplies industry. AORT has an average financial health and profitability rating. AORT is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
AORT had negative earnings in the past year.
AORT had a positive operating cash flow in the past year.
AORT had negative earnings in each of the past 5 years.
In multiple years AORT reported negative operating cash flow during the last 5 years.
1.2 Ratios
The Return On Assets of AORT (-2.13%) is better than 68.78% of its industry peers.
AORT has a better Return On Equity (-4.26%) than 69.31% of its industry peers.
AORT's Return On Invested Capital of 2.15% is fine compared to the rest of the industry. AORT outperforms 69.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.13% | ||
| ROE | -4.26% | ||
| ROIC | 2.15% |
ROA(3y)-2.68%
ROA(5y)-2.4%
ROE(3y)-7.46%
ROE(5y)-6.47%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a decent Operating Margin value of 5.18%, AORT is doing good in the industry, outperforming 69.84% of the companies in the same industry.
AORT's Operating Margin has improved in the last couple of years.
The Gross Margin of AORT (63.99%) is better than 67.20% of its industry peers.
In the last couple of years the Gross Margin of AORT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.18% | ||
| PM (TTM) | N/A | ||
| GM | 63.99% |
OM growth 3Y34.21%
OM growth 5Y6.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.05%
GM growth 5Y-0.68%
2. Health
2.1 Basic Checks
AORT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for AORT has been increased compared to 1 year ago.
AORT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, AORT has a worse debt to assets ratio.
2.2 Solvency
AORT has an Altman-Z score of 3.92. This indicates that AORT is financially healthy and has little risk of bankruptcy at the moment.
AORT has a better Altman-Z score (3.92) than 73.02% of its industry peers.
The Debt to FCF ratio of AORT is 28.63, which is on the high side as it means it would take AORT, 28.63 years of fcf income to pay off all of its debts.
AORT has a Debt to FCF ratio of 28.63. This is in the better half of the industry: AORT outperforms 67.72% of its industry peers.
AORT has a Debt/Equity ratio of 0.52. This is a neutral value indicating AORT is somewhat dependend on debt financing.
AORT's Debt to Equity ratio of 0.52 is in line compared to the rest of the industry. AORT outperforms 40.74% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.52 | ||
| Debt/FCF | 28.63 | ||
| Altman-Z | 3.92 |
ROIC/WACC0.25
WACC8.44%
2.3 Liquidity
AORT has a Current Ratio of 4.78. This indicates that AORT is financially healthy and has no problem in meeting its short term obligations.
AORT's Current ratio of 4.78 is fine compared to the rest of the industry. AORT outperforms 76.72% of its industry peers.
A Quick Ratio of 3.48 indicates that AORT has no problem at all paying its short term obligations.
AORT has a better Quick ratio (3.48) than 70.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.78 | ||
| Quick Ratio | 3.48 |
3. Growth
3.1 Past
The earnings per share for AORT have decreased strongly by -12.12% in the last year.
Looking at the last year, AORT shows a small growth in Revenue. The Revenue has grown by 7.44% in the last year.
The Revenue has been growing slightly by 7.06% on average over the past years.
EPS 1Y (TTM)-12.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%260%
Revenue 1Y (TTM)7.44%
Revenue growth 3Y9.14%
Revenue growth 5Y7.06%
Sales Q2Q%15.26%
3.2 Future
AORT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 46.79% yearly.
AORT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.19% yearly.
EPS Next Y126.16%
EPS Next 2Y71.48%
EPS Next 3Y51.07%
EPS Next 5Y46.79%
Revenue Next Year11.67%
Revenue Next 2Y11.28%
Revenue Next 3Y11.47%
Revenue Next 5Y11.19%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for AORT. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 113.13, the valuation of AORT can be described as expensive.
AORT's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. AORT is cheaper than 66.67% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of AORT to the average of the S&P500 Index (22.27), we can say AORT is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 113.13 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, AORT is valued a bit cheaper than 66.14% of the companies in the same industry.
67.20% of the companies in the same industry are more expensive than AORT, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 281.74 | ||
| EV/EBITDA | 52.32 |
4.3 Compensation for Growth
AORT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AORT's earnings are expected to grow with 51.07% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y71.48%
EPS Next 3Y51.07%
5. Dividend
5.1 Amount
No dividends for AORT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
45.76
+0.07 (+0.15%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners84.01%
Inst Owner ChangeN/A
Ins Owners4.41%
Ins Owner Change-1.55%
Market Cap2.16B
Revenue(TTM)405.04M
Net Income(TTM)-17899000
Analysts83.08
Price Target46.16 (0.87%)
Short Float %3.12%
Short Ratio3.43
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1009.98%
Min EPS beat(2)91.71%
Max EPS beat(2)1928.24%
EPS beat(4)3
Avg EPS beat(4)376.32%
Min EPS beat(4)-537.25%
Max EPS beat(4)1928.24%
EPS beat(8)5
Avg EPS beat(8)158.13%
EPS beat(12)8
Avg EPS beat(12)112.3%
EPS beat(16)10
Avg EPS beat(16)39.11%
Revenue beat(2)2
Avg Revenue beat(2)2.37%
Min Revenue beat(2)2.16%
Max Revenue beat(2)2.59%
Revenue beat(4)2
Avg Revenue beat(4)-0.38%
Min Revenue beat(4)-5.37%
Max Revenue beat(4)2.59%
Revenue beat(8)5
Avg Revenue beat(8)0.72%
Revenue beat(12)7
Avg Revenue beat(12)0.63%
Revenue beat(16)10
Avg Revenue beat(16)0.53%
PT rev (1m)6.74%
PT rev (3m)38.34%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-36.85%
EPS NY rev (1m)-1.27%
EPS NY rev (3m)0.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.78%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)2.42%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 113.13 | ||
| P/S | 5.33 | ||
| P/FCF | 281.74 | ||
| P/OCF | 109.86 | ||
| P/B | 5.14 | ||
| P/tB | 281.85 | ||
| EV/EBITDA | 52.32 |
EPS(TTM)-0.37
EYN/A
EPS(NY)0.4
Fwd EY0.88%
FCF(TTM)0.16
FCFY0.35%
OCF(TTM)0.42
OCFY0.91%
SpS8.58
BVpS8.9
TBVpS0.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.13% | ||
| ROE | -4.26% | ||
| ROCE | 2.72% | ||
| ROIC | 2.15% | ||
| ROICexc | 2.31% | ||
| ROICexgc | 5.42% | ||
| OM | 5.18% | ||
| PM (TTM) | N/A | ||
| GM | 63.99% | ||
| FCFM | 1.89% |
ROA(3y)-2.68%
ROA(5y)-2.4%
ROE(3y)-7.46%
ROE(5y)-6.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y40.9%
ROICexgc growth 5Y5.66%
ROICexc growth 3Y48.24%
ROICexc growth 5Y9.09%
OM growth 3Y34.21%
OM growth 5Y6.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.05%
GM growth 5Y-0.68%
F-Score4
Asset Turnover0.48
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.52 | ||
| Debt/FCF | 28.63 | ||
| Debt/EBITDA | 4.93 | ||
| Cap/Depr | 51.26% | ||
| Cap/Sales | 2.96% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 44.29% | ||
| Profit Quality | N/A | ||
| Current Ratio | 4.78 | ||
| Quick Ratio | 3.48 | ||
| Altman-Z | 3.92 |
F-Score4
WACC8.44%
ROIC/WACC0.25
Cap/Depr(3y)42.06%
Cap/Depr(5y)43.23%
Cap/Sales(3y)2.8%
Cap/Sales(5y)3.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%260%
EPS Next Y126.16%
EPS Next 2Y71.48%
EPS Next 3Y51.07%
EPS Next 5Y46.79%
Revenue 1Y (TTM)7.44%
Revenue growth 3Y9.14%
Revenue growth 5Y7.06%
Sales Q2Q%15.26%
Revenue Next Year11.67%
Revenue Next 2Y11.28%
Revenue Next 3Y11.47%
Revenue Next 5Y11.19%
EBIT growth 1Y-22.98%
EBIT growth 3Y46.49%
EBIT growth 5Y14.43%
EBIT Next Year112.29%
EBIT Next 3Y43.08%
EBIT Next 5Y32.16%
FCF growth 1Y224.1%
FCF growth 3YN/A
FCF growth 5Y7.33%
OCF growth 1Y335.36%
OCF growth 3YN/A
OCF growth 5Y7.04%
ARTIVION INC / AORT FAQ
Can you provide the ChartMill fundamental rating for ARTIVION INC?
ChartMill assigns a fundamental rating of 4 / 10 to AORT.
Can you provide the valuation status for ARTIVION INC?
ChartMill assigns a valuation rating of 4 / 10 to ARTIVION INC (AORT). This can be considered as Fairly Valued.
Can you provide the profitability details for ARTIVION INC?
ARTIVION INC (AORT) has a profitability rating of 4 / 10.
Can you provide the financial health for AORT stock?
The financial health rating of ARTIVION INC (AORT) is 5 / 10.